ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
DRUG Bright Minds Biosciences Inc
- 58.370
- +2.860+5.15%
15min DelayMarket Closed Dec 13 15:13 ET
407.10MMarket Cap-66.33P/E (TTM)
59.460High57.630Low802Volume57.630Open55.510Pre Close47.05KTurnover108.00052wk High0.03%Turnover Ratio6.97MShares1.29052wk Low-0.88EPS TTM153.86MFloat Cap108.000Historical HighLossP/E (Static)2.64MShs Float1.290Historical Low-1.98EPS LYR3.30%Amplitude--Dividend TTM66.71P/B1Lot Size--Div YieldTTM
Bright Minds Biosciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -116.21%-234.74K | -72.83%558.06K | -26.08%1.7M | -50.68%7.39M | -47.33%1.59M | -45.61%1.45M | -54.12%2.05M | -52.36%2.3M | 70.44%14.98M | 1.50%3.01M |
| Selling and administrative expenses | -15.69%320.64K | -35.38%363.6K | -49.71%401.18K | -13.77%2.2M | 6.57%459.16K | -36.96%380.32K | -12.17%562.64K | -8.98%797.69K | 11.38%2.55M | -42.16%430.86K |
| -Selling and marketing expense | --0 | --0 | -10.88%36.6K | -78.36%119.42K | -50.93%36.6K | -53.69%37.1K | -97.37%4.65K | -81.36%41.07K | -35.24%551.86K | -49.07%74.59K |
| -General and administrative expense | -6.58%320.64K | -34.84%363.6K | -51.81%364.58K | 4.06%2.08M | 18.61%422.56K | -34.39%343.22K | 20.33%557.99K | 15.33%756.62K | 39.00%2M | -40.48%356.27K |
| Research and development costs | -153.94%-566.75K | -92.48%105.18K | -16.04%1.23M | -58.95%5M | -57.06%1.09M | -48.78%1.05M | -62.65%1.4M | -62.04%1.46M | 92.92%12.18M | 15.08%2.54M |
| Other operating expenses | -33.88%11.36K | -4.08%89.29K | 76.65%72.29K | -23.21%186.65K | -9.37%35.45K | 114.56%17.19K | -0.45%93.09K | -60.05%40.92K | 33.75%243.08K | 189.84%39.12K |
| Operating profit | 116.21%234.74K | 72.83%-558.06K | 26.08%-1.7M | 50.68%-7.39M | 47.33%-1.59M | 45.61%-1.45M | 54.12%-2.05M | 52.36%-2.3M | -70.44%-14.98M | -1.50%-3.01M |
| Net non-operating interest income (expenses) | 14.99K | 0 | 0 | 0 | 0 | |||||
| Non-operating interest income | --14.99K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -96.18%-19.83K | -560.06%-16.08K | 139.67%14.73K | 39.78%14.19K | 15.47%57.93K | -336.51%-10.11K | 134.24%3.5K | -8.94%-37.13K | -93.41%10.15K | -49.64%50.17K |
| Gain on sale of security | -96.18%-19.83K | -560.06%-16.08K | 139.67%14.73K | 16.77%14.19K | 11.05%57.93K | -336.51%-10.11K | 134.24%3.5K | -8.94%-37.13K | -92.11%12.15K | -47.64%52.17K |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---2K | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2K | ---- |
| Income before tax | 115.77%229.9K | 72.00%-574.14K | 27.88%-1.68M | 50.74%-7.37M | 48.40%-1.53M | 45.14%-1.46M | 54.31%-2.05M | 51.93%-2.34M | -72.99%-14.96M | -3.28%-2.96M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 115.77%229.9K | 72.00%-574.14K | 27.88%-1.68M | 50.74%-7.37M | 48.40%-1.53M | 45.14%-1.46M | 54.31%-2.05M | 51.93%-2.34M | -72.99%-14.96M | -3.28%-2.96M |
| Net income continuous operations | 115.77%229.9K | 72.00%-574.14K | 27.88%-1.68M | 50.74%-7.37M | 48.40%-1.53M | 45.14%-1.46M | 54.31%-2.05M | 51.93%-2.34M | -72.99%-14.96M | -3.28%-2.96M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 115.77%229.9K | 72.00%-574.14K | 27.88%-1.68M | 50.74%-7.37M | 48.40%-1.53M | 45.14%-1.46M | 54.31%-2.05M | 51.93%-2.34M | -72.99%-14.96M | -3.28%-2.96M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 115.77%229.9K | 72.00%-574.14K | 27.88%-1.68M | 50.74%-7.37M | 48.40%-1.53M | 45.14%-1.46M | 54.31%-2.05M | 51.93%-2.34M | -72.99%-14.96M | -3.28%-2.96M |
| Diluted earnings per share | 112.82%0.05 | 75.93%-0.13 | 32.31%-0.44 | 67.33%-1.98 | 60.40%-0.4 | 65.18%-0.39 | 71.58%-0.54 | 68.29%-0.65 | -25.73%-6.06 | 17.21%-1.01 |
| Basic earnings per share | 112.82%0.05 | 75.93%-0.13 | 32.31%-0.44 | 67.33%-1.98 | 60.40%-0.4 | 65.18%-0.39 | 71.58%-0.54 | 68.29%-0.65 | -25.73%-6.06 | 17.21%-1.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.